| Trial ID: | L4625 |
| Source ID: | NCT03508323
|
| Associated Drug: |
Teneligliptin
|
| Title: |
Tenelia Elderly CGMS Study(TEDDY)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Teneligliptin|DRUG: Placebo
|
| Outcome Measures: |
Primary: HbA1c, Change of HbA1c, after 12wks on baseline |
|
| Sponsor/Collaborators: |
Sponsor: Handok Inc.
|
| Gender: |
ALL
|
| Age: |
OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
65
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2018-04-03
|
| Completion Date: |
2019-12-12
|
| Results First Posted: |
|
| Last Update Posted: |
2022-06-30
|
| Locations: |
Samsung Medical Center, Seoul, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT03508323
|
